ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ATAI ATAI Life Sciences NV

1.37
0.03 (2.24%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ATAI Life Sciences NV ATAI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.03 2.24% 1.37 17:23:41
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.35 1.33 1.38 1.37 1.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202407:00EDGAR2Form 8-K - Current report
31/5/202406:00GLOBEatai Life Sciences to Participate in the Jefferies 2024..
23/5/202406:10EDGAR2Form 8-K - Current report
23/5/202406:00GLOBEatai Life Sciences Strengthens Board with Appointment of Two..
20/5/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202406:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202406:15EDGAR2Form 8-K - Current report
15/5/202405:59GLOBEatai Life Sciences Reports First Quarter 2024 Financial..
24/4/202406:00GLOBEatai Life Sciences Announces Dosing of First Patient in Part..
17/4/202406:00GLOBEatai Life Sciences Announces the Publication of Beckley..
28/3/202406:00GLOBEatai Life Sciences Reports Fourth Quarter and Full Year 2023..
27/3/202406:00GLOBEatai Life Sciences Announces Positive Initial Results from..
04/3/202407:00GLOBEatai Life Sciences Announces First Participant Dosed in..
28/2/202416:00GLOBEatai Life Sciences to Participate in the Upcoming TD Cowen..
13/2/202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202416:05EDGAR2Form 8-K - Current report
06/2/202416:00GLOBEatai Life Sciences Appoints Anne Johnson as Chief Financial..
23/1/202406:46EDGAR2Form 8-K - Current report
09/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:28EDGAR2Form 8-K - Current report
04/1/202407:53EDGAR2Form 8-K - Current report
04/1/202406:20EDGAR2Form 8-K - Current report
04/1/202406:00GLOBEatai Life Sciences Announces Strategic Investment in Beckley..
02/1/202407:00GLOBEatai Life Sciences Announces Positive Topline Results from..
20/11/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:03GLOBEatai Life Sciences Reports Third Quarter 2023 Financial..
13/10/202315:15EDGAR2Form 8-K - Current report
10/10/202307:00PRNCAATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT
06/10/202315:05GLOBEatai Life Sciences to Participate in the Jefferies Inaugural..
02/10/202315:13GLOBEatai Life Sciences Announces Completion of Phase 1 Study of..
29/9/202315:38EDGAR2Form 8-K - Current report
14/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202307:02GLOBEatai Life Sciences to Participate in the 2023 Cantor..
06/9/202315:01GLOBEatai Life Sciences to Participate in Upcoming September..
31/8/202315:17EDGAR2Form 8-K - Current report
10/8/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:42EDGAR2Form 8-K - Current report
10/8/202305:59GLOBEatai Life Sciences Reports Second Quarter 2023 Financial..
08/8/202315:02GLOBEatai Life Sciences Announces Results from the Phase 1..

Su Consulta Reciente

Delayed Upgrade Clock